{"id":"W1993251619","doi":"10.1016/j.vph.2005.11.011","title":"Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: Relation to dysregulated phosphatidylcholine metabolism","year":2006,"lang":"en","type":"article","venue":"Vascular Pharmacology","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":false,"ca_institutions":"Canadian Institutes of Health Research; University of Alberta","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; American Diabetes Association; American Heart Association; National Institutes of Health","keywords":"Rosiglitazone; Type 2 diabetes; Insulin resistance; Endocrinology; Internal medicine; Fenofibrate; Medicine; Bezafibrate; Adiponectin; Metabolic syndrome; Peroxisome proliferator-activated receptor; Insulin; Diabetes mellitus; Pharmacology; Receptor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003206973,0.0002111402,0.0003698606,0.0002408392,0.00003418071,0.000006222528,0.0001337161,0.0002132097,0.00002109704],"category_scores_gemma":[0.0001159404,0.0002195589,0.00008849678,0.000402562,0.00004584809,0.00001270539,0.000129137,0.0001145165,0.000009261365],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004291257,"about_ca_system_score_gemma":0.0001720812,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001249085,"about_ca_topic_score_gemma":0.00001735532,"domain_scores_codex":[0.9985101,0.0002344273,0.0003550578,0.0004306347,0.0001429921,0.0003268539],"domain_scores_gemma":[0.9993557,0.00002349489,0.00007810799,0.0002452114,0.0001212033,0.0001762682],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004441688,0.00009301923,0.008246167,0.00001705543,0.0001407011,6.173024e-7,0.0001119547,0.02678091,0.9627507,0.00001672623,0.001106716,0.00029128],"study_design_scores_gemma":[0.001422916,0.0001734228,0.007753388,0.00001036671,0.0001004452,3.46532e-7,0.00001115609,0.002725651,0.9834128,0.0000214741,0.004135266,0.0002327558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956535,0.002725272,0.0005125303,0.0001921421,0.000210676,0.0006308764,0.00003762181,0.00002126484,0.00001612335],"genre_scores_gemma":[0.9958089,0.0003149015,0.002624501,0.0003673194,0.0001372914,0.0000495171,0.00008185391,0.00004049682,0.0005751909],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02405526,"threshold_uncertainty_score":0.8953351,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008404758484741096,"score_gpt":0.2494761991593751,"score_spread":0.241071440674634,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}